Ian McLeod

2018

In 2018, Ian McLeod earned a total compensation of $952.4K as Interim Chief Financial Officer at ABIOMED.

Compensation breakdown

Non-Equity Incentive Plan$167,124
Option Awards$147,498
Salary$261,131
Stock Awards$376,628
Total$952,381

McLeod received $376.6K in stock awards, accounting for 40% of the total pay in 2018.

McLeod also received $167.1K in non-equity incentive plan, $147.5K in option awards and $261.1K in salary.

Rankings

In 2018, Ian McLeod's compensation ranked 9,438th out of 14,244 executives tracked by ExecPay. In other words, McLeod earned more than 33.7% of executives.

ClassificationRankingPercentile
All
9,438
out of 14,244
34th
Division
Manufacturing
3,786
out of 5,759
34th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
503
out of 849
41st
Industry group
Surgical, Medical, And Dental Instruments And Supplies
307
out of 547
44th
Industry
Surgical and Medical Instruments and Apparatus
193
out of 348
45th
Source: SEC filing on June 22, 2018.

McLeod's colleagues

We found five more compensation records of executives who worked with Ian McLeod at ABIOMED in 2018.

2018

Michael Minogue

ABIOMED

Chief Executive Officer

2018

David Weber

ABIOMED

Chief Operating Officer

2018

Michael Howley

ABIOMED

Vice President and General Manager, Global Sales

2018

William Bolt

ABIOMED

Senior Vice President, Global Quality, Regulatory and Clinical Operations

2018

Michael Tomsicek

ABIOMED

Chief Financial Officer

News

You may also like